Related Experiment Video
Updated: Jan 20, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Low deceleration capacity is associated with higher stroke risk in patients with paroxysmal atrial fibrillation
Ying Ding1, Zhen-Yan Xu1,2, Hua-Long Liu1
1Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Insights
Lower deceleration capacity (DC) in paroxysmal atrial fibrillation (AF) patients is linked to a higher risk of stroke. This finding suggests DC may serve as a potential indicator for stroke risk assessment in AF.
Area of Science:
- Cardiology
- Autonomic Nervous System Function
- Stroke Risk Assessment
Background:
- Deceleration capacity (DC) is a marker for cardiac autonomic dysfunction.
- Limited research exists on DC's influencing factors and stroke risk correlation in paroxysmal atrial fibrillation (AF).
Purpose of the Study:
- To explore factors influencing abnormal DC in paroxysmal AF patients.
- To investigate the relationship between DC and stroke risk in paroxysmal AF.
Main Methods:
- Analyzed 24-h Holter ECG data from 259 hospitalized paroxysmal AF patients.
- Utilized multivariable regression to identify factors associated with abnormal DC.
- Assessed the correlation between DC and ischemic stroke risk scores (CHADS2, CHA2DS2-VASc).
Main Results:
- A history of stroke or transient ischemic attack (TIA) was independently associated with abnormal DC (OR=2.861).
- Patients with abnormal DC had significantly higher CHADS2 and CHA2DS2-VASc scores.
- DC showed a negative correlation with both CHADS2 (r=-0.290) and CHA2DS2-VASc (r=-0.263) scores.
Conclusions:
- Lower DC is strongly associated with prior stroke/TIA in paroxysmal AF.
- Reduced DC correlates with increased stroke risk scores, indicating its potential as a stroke risk indicator.
Background:
Deceleration capacity (DC) is a non-invasive marker for cardiac autonomic dysfunction; however, few studies have shown that the influence factors of cardiac autonomic dysfunction and the correlations between DC and stroke risk in paroxysmal atrial fibrillation (AF). We aimed to explore the influencing factors of abnormal DC and the relationships between DC and stroke risk in patients with paroxysmal AF.
Methods:
The study included hospitalized paroxysmal AF patients with DC measurements derived from 24-h Holter electrocardiography recordings taken between August 2015 and June 2016. Multivariable regression analysis was performed to evaluate the associations between correlated variables and abnormal DC values. The relationship between DC and ischemic stroke risk scores in patients with paroxysmal AF was analyzed.
Results:
We studied 259 hospitalized patients with paroxysmal AF (143 [55.2%] male, mean age 66.4 ± 12.0 years); 38 patients of them showed abnormal DC values. In the univariate analysis, age, hypertension, heart failure, and previous stroke/transient ischemic attack (TIA) were significantly associated with abnormal DC values. Among these factors, a history of previous stroke/TIA (odds ratio = 2.861, 95% confidence interval: 1.356-6.039) were independently associated with abnormal DC values in patients with paroxysmal AF. The abnormal DC group showed a higher stroke risk with the score of congestive heart failure, hypertension, age >75 years, diabetes mellitus, previous stroke and TIA (CHADS2) (2.25 ± 1.48 vs. 1.40 ± 1.34, t = -4.907, P = 0.001) and CHA2DS2-vascular disease, age 65-74 years and female category (VASc) (3.76 ± 1.95 vs. 2.71 ± 1.87, t = -4.847, P = 0.001) scores. Correlation analysis showed that DC was negatively correlated with CHADS2 scores (r = -0.290, P < 0.001) and CHA2DS2-VASc scores (r = -0.263, P < 0.001).
Conclusions:
Lower DC is closely associated with previous stroke/TIA, and is also correlated negatively with higher stroke risk scores in patients with paroxysmal AF. It could be a potential indicator of stroke risk in paroxysmal AF patients.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
Lung Capacity
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Relative Risk

